1)Fung M, Jacobsen E, Freedman A et al:Increased risk of infectious complications in older patients with indolent non-hodgkin lymphoma exposed to bendamustine. Clin Infect Dis 68:247-255, 2019
2)Demitrovicova L, Mikuskova E, Oravcovaet I et al:Infectious complications in chronic lymphocytic leukemia- a retrospective analysis:single institution experience. Neoplasma 3:474-481, 2017
3)Hosoda T, Yokoyama A, Yoneda M et al:Bendamustine can severely impair T-cell immunity against cytomegalovirus. Leuk Lymphoma 54:1327-1328, 2013
4)Hasegawa T, Aisa Y, Shimazaki K et al:Cytomegalovirus reactivation with bendamustine in patients with low-grade B-cell lymphoma. Ann Hematol 94:515-517, 2015
5)Song MK, Karavellas MP, MacDonald JC et al:Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy. Retina 20:151-155, 2000
6)Yamasaki S, Kohno K, Kadowaki M et al:Cytomegalovirus retinitis in relapsed or refractory low-grade B cell lymphoma patients treated with bendamustine. Ann Hematol 96:1215-1217, 2017
7)竹内 大:サイトメガロウイルス網膜炎.臨眼73:272-276,2019
8)Schneider EW, Elner SG, Kuijk FJ et al:Chronic retinal necrosis:cytomegalovirus necrotizing retinitis associated with panretinal vasculopathy in non-HIV patients. Retina 33:1791-1799, 2013
9)柳田淳子・蕪城俊克・田中理恵・他:近年のサイトメガロウイルス網膜炎の臨床像の検討.あたらしい眼科32:699-703,2015
10)Marcus R, Davies A, Ando K et al:Obinutuzumab for the First-Line Treatment of Follicular Lymphoma. N Eng J Med 377:1331-1344, 2017
11)Park LC, Lee HS, Shin SH et al:Herpesviridae viral infections following rituximab combined chemotherapy in patients with diffuse large B-cell lymphoma. Acta Haematologica 125:230-236, 2011